CVS Health Corp vs VanEck Junior Gold Miners — how do they compare? CVS Health Corp trades at $85.29 (market cap $112.29B), while VanEck Junior Gold Miners trades at $113.17 (market cap $8.22B). The key difference: CVS Health Corp is far larger — about 13.7× VanEck Junior Gold Miners's market cap, and CVS Health Corp pays a 3.03% dividend while VanEck Junior Gold Miners pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and VanEck Junior Gold Miners for 41 Days on average.
| CVS | GDXJ | |
|---|---|---|
Market Cap | $112.29B | $8.22B |
Volume | 7,763,676 | 3,212,198 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $110.60 | $156.19 |
52-Week Low | $70.08 | $87.56 |
Typical Hold Time | 83 Days | 41 Days |
Enterprise Value | $174.64B | — |
Dividend Yield | 3.03% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
GDXJ, the VanEck Junior Gold Miners ETF, is trading at $109.14, down 3.88% on the day, reflecting a bearish technical signal with selling pressure across moving averages and oscillators. Recent news highlights multiple junior gold mining companies being added to the ETF's index, potentially increasing its diversification and appeal. The ETF's current price is near key support levels, with the overall market sentiment influenced by gold price volatility and sector-specific developments.
The outlook for GDXJ is cautious due to bearish technical indicators and sector volatility, though inclusion of new companies may enhance long-term growth potential. Key risks include gold price fluctuations, mining operational risks, and broader market sentiment shifts. Investment opportunity lies in potential gold price appreciation and ETF rebalancing benefits, but requires careful risk management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →